For Dr. Joseph Cacchione, the math on GLP-1 drugs stopped making sense. For Dr. Joseph Cacchione, the math on GLP-1 drugs stopped making sense.
This CEO wants to cover weight loss drugs for employees. They’re just too expensive.This CEO wants to cover weight loss drugs for employees. They’re just too expensive.
